Journal de la science et de la recherche sur le cancer
Libre accès

Abstrait

A Short Note on Metastatic Cancer and Its Resistance

Alex Pajno*

Metastatic cancer, characterized by the spread of cancer cells from the primary tumor to distant sites in the body, is a immense difficulty in oncology. This resistance can develop as insensitivity to chemotherapy, targeted therapies, immunotherapies, or hormonal treatments, making metastatic cancer extremely difficult to control. Understanding the mechanisms behind treatment resistance is essential for improving patient outcomes. Metastatic cancer cells use a range of adaptive strategies to evade the effects of therapeutic interventions. These mechanisms may involve genetic alterations, such as the development of unexpected mutations or gene amplifications that render cancer cells less susceptible to treatment. Additionally, cancer cells can activate signaling pathways that elevate their survival and growth, preventing the intended effects of drugs. The heterogeneity of metastatic tumors, both within a single patient and across different patients, further complicates the challenge of treatment resistance. This complexity underscores the need for personalized medicine approaches that consider the distinct genetic and molecular characteristics of each patient's cancer.